Scleroderma News

Boehringer Ingelheim announced nintedanib has been granted orphan drug designation by the European Commission and the FDA for the treatment of systemic sclerosis, including associated interstitial lung disease.

Results from this study found CT scans that indicated the presence of ankylosis or showed a total erosion score of at least three could be used to identify patients at high risk of sacroiliitis.

Women with systemic sclerosis who were married had lower scores for depressive symptoms compared with unmarried women, according to results.

The National Institute on Minority Health and Health Disparities announced it will be launching the Transdisciplinary Collaborative Centers for Health Disparities Research on Chronic Disease Prevention program.

A Crohn’s disease patient who complains of joint pain should first be queried as to the location, character (presence or absence of inflammatory features), associated musculoskeletal features of a seronegative spondyloarthropathy and correlation of joint pain to the activity of the Crohn’s Disease.

The survival rate was worse for patients with systemic sclerosis/polymyositis overlap vs. systemic sclerosis, according to study results.

A new scleroderma body concealment scale has been developed by the Canadian Scleroderma Research Group as an index of social avoidance by patients with systemic sclerosis, according to a recently published report.

The NIH announced $55 million in awards for fiscal year 2016 to launch a key component of President Barack Obama’s Precision Medicine Initiative.

Researchers found pirfenidone had an acceptable tolerability profile for the treatment of patients with systemic sclerosis-associated interstitial lung disease and suggested tolerability may improve with longer titration.

The insertion of an implantable loop recorder in patients with systemic sclerosis and no known heart disease allowed for early detection and treatment of cardiac conduction abnormalities, including serious cardiac arrhythmias, according to results presented at the EULAR Annual Congress.